STOCK TITAN

AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

AbbVie (NYSE: ABBV) has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference scheduled for Tuesday, September 9, 2025.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

AbbVie (NYSE: ABBV) has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference scheduled for Tuesday, September 9, 2025. The company's management will engage in a fireside chat presentation at 9:00 a.m. Central time.

Investors can access the presentation through a live audio webcast on AbbVie's Investor Relations website at investors.abbvie.com. An archived version of the session will be made available later the same day.

Loading...
Loading translation...
Argus Sep 2 session
+0.72% close to close Open Argus
Details

News Market Reaction – ABBV

On Sep 2, the day this news came out, ABBV closed 0.72% above the previous close.

Data tracked by StockTitan Argus for the Sep 2 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NORTH CHICAGO, Ill., Sept. 2, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025. Management will participate in a fireside chat at 9:00 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube. 

Media:

Gabby Tarbert   
(224) 244-0111

Investors:

Liz Shea
(847) 935-2211

gabrielle.tarbert@abbvie.com

liz.shea@abbvie.com

AbbVie logo

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference-302542190.html

SOURCE AbbVie

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is AbbVie (ABBV) presenting at the Morgan Stanley Healthcare Conference 2025?

AbbVie will present on Tuesday, September 9, 2025 at 9:00 a.m. Central time in a fireside chat format.

How can investors watch AbbVie's Morgan Stanley conference presentation?

Investors can watch the presentation via live audio webcast on AbbVie's Investor Relations website at investors.abbvie.com.

Will AbbVie's Morgan Stanley conference presentation be available after the event?

Yes, an archived version of the presentation will be available on AbbVie's Investor Relations website later the same day.

What type of presentation will AbbVie give at the Morgan Stanley Healthcare Conference?

AbbVie's management will participate in a fireside chat presentation format at the conference.

Keep reading